Registered entities
Quince Therapeutics, Inc.
Reg. No. 1662774United States
Social engagement
Social engagement: 3.8K social following, 10 posts in the last 12 months — above the industry median.
Investor mix
28 investors on record; lead investors include Breakout Labs, Pfizer Venture Investments, Takeda Ventures, Balyasny Asset Management; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 36% |
| Private equity | 4 | 14% |
| Angel & family office | 1 | 4% |
| Accelerator & incubator | 1 | 4% |
| Bank & private debt | 1 | 4% |
| Other / undisclosed | 11 | 39% |
Recent activity
9 Feb 2026
Partnership
LifeSci Capital
29 Jan 2026
Product launch
eDSP
28 Jan 2026
Event
British Paediatric Neurology Association 2026 Annual Meeting